Better late than never: AstraZeneca finally pushes potassium drug Lokelma to the FDA finish line
admin 21st May 2018 Uncategorised 0Third time’s the charm for AstraZeneca’s blockbuster hopeful Lokelma, formerly known as ZS-9—and known for its two-in-a-row rejections on manufacturing shortfalls. With an FDA approval in hand, the drug is now ready to take on Vifor’s Veltassa.
More: Better late than never: AstraZeneca finally pushes potassium drug Lokelma to the FDA finish line
Source: fierce